You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Sep 2025
Drug

Published Date: 02 Sep 2025

Revision Summary:


Drug Monograph: Added NDFP form

Sep 2025
Drug

Published Date: 21 Aug 2025

Revision Summary:
Drug Monograph: Updated Dosing, Administration and Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.
Patient Info Sheet EN: Updated patient medication information sheet
Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Added BELA maintenance information

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures, Dose Modifications, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Modifications and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Gynecologic, 
Ovary
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Drug

Published Date: 20 Aug 2025

Revision Summary:
Drug Monograph: Updated Special Precautions section
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d'information mise à jour/révisée)
Aug 2025

Pages